Suzanne Staudinger
Geriatric Medicine · Benton City, WANPI 1861572737
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2022 at $603 and has fallen 56.3% since, to $264 in 2025. Among geriatric medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$771
- AstraZeneca$370
- GSK$209
- Otsuka America Pharmaceutical, Inc.$150
- Boehringer Ingelheim$134
- Mylan Specialty L.p.$124
- plus $701 from 15 others
What the payments were for
- Food & beverage$2,43699%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $771 |
| AstraZeneca | 12 | $370 |
| GSK | 5 | $209 |
| Otsuka America Pharmaceutical, Inc. | 4 | $150 |
| Boehringer Ingelheim | 5 | $134 |
| Mylan Specialty L.p. | 6 | $124 |
| Pfizer | 7 | $122 |
| Johnson & Johnson | 4 | $102 |
| Sanofi-aventis U.S. LLC | 4 | $90 |
| Medtronic(2 entities) | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Merck | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Sanofi Pasteur Inc. | 2 | $40 |
| Novo Nordisk | 2 | $31 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Alk-abello, Inc | 1 | $21 |
| Bayer | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,459 in reported general payments places this provider in the 90th percentile of 77 geriatric medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 106 | $110,764 |
| JardianceEmpagliflozin | 53 | $58,840 |
| EliquisApixaban | 51 | $38,697 |
| WegovySemaglutide | 14 | $24,390 |
| MyrbetriqMirabegron | 22 | $22,652 |
| RybelsusSemaglutide | 15 | $22,017 |
| XareltoRivaroxaban | 21 | $20,113 |
| FarxigaDapagliflozin Propanediol | 18 | $18,115 |
| Bydureon BciseExenatide Microspheres | 21 | $16,234 |
| MounjaroTirzepatide | 15 | $16,162 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 21 | $15,379 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 271 | $9,292 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $8,721 |
| LinzessLinaclotide | 15 | $8,605 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy, Rybelsus | $31 | $157,171135 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat | $134 | $82,54590 claims |
| PfizerEliquis | $122 | $38,69751 claims |
| AstraZenecaFarxiga, Symbicort | $370 | $23,95933 claims |
| Johnson & JohnsonXarelto | $102 | $20,11321 claims |
| GSKIncruse Ellipta, Arnuity Ellipta | $209 | $8,96629 claims |
| AbbVieLinzess | $771 | $8,60515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 77 geriatric medicine providers in Washington.
Other geriatric medicine in Benton City
- Candice PollardBenton City$190
- John Dugawla Conner$34K
- Angela HansonSeattle$12K
- Neeti MittalMercer Island$7K
- Richard KanerBellevue$5K
- Sabine von Preyss-FriedmanSeattle$3K
- Lacee MeyerBellevue$3K
- Kristina SwiggumSpokane Valley$2K
- Ellyn LeeSeattle$2K
- Michi YukawaSeattle$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.